0000950170-23-035685.txt : 20230731
0000950170-23-035685.hdr.sgml : 20230731
20230731075959
ACCESSION NUMBER: 0000950170-23-035685
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230727
FILED AS OF DATE: 20230731
DATE AS OF CHANGE: 20230731
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PERRY DAVID P
CENTRAL INDEX KEY: 0001105941
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39864
FILM NUMBER: 231125070
MAIL ADDRESS:
STREET 1: 1020 EAST MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Better Therapeutics, Inc.
CENTRAL INDEX KEY: 0001832415
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 548 MARKET ST. #49404
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
BUSINESS PHONE: 415-887-2311
MAIL ADDRESS:
STREET 1: 548 MARKET ST. #49404
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
FORMER COMPANY:
FORMER CONFORMED NAME: Mountain Crest Acquisition Corp II
DATE OF NAME CHANGE: 20201116
4
1
ownership.xml
4
X0508
4
2023-07-27
false
0001832415
Better Therapeutics, Inc.
BTTX
0001105941
PERRY DAVID P
C/O BETTER THERAPEUTICS, INC.
548 MARKET STREET, #49404
SAN FRANCISCO
CA
94104
true
true
true
Executive Chairman
false
Common Stock
2023-07-27
4
P
false
1233045
0.7299
A
13030393
I
By Perry Trust
Common Stock
3636364
I
By Maule-fFinch Trust
Common Stock
293150
I
By spouse
Common Stock
21336
I
By Pensus Limited Trust
Common Stock
101536
D
On July 25, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.7299 per share.
As one of the PIPE Investors, the David P. Perry 2015 Trust (the "Perry Trust") acquired 1,233,045 shares of Issuer common stock on July 27, 2023 for $0.7299 per share.
These shares are owned directly by the Perry Trust, a ten percent owner of the Issuer, and indirectly by David P. Perry ("Perry") as trustee of the Perry Trust. Perry is an officer, director and ten percent owner of the Issuer.
These shares are owned directly by the Georgianna Maule-Ffinch 2015 Trust (the "Maule-Ffinch Trust"), a ten percent owner of the Issuer and indirectly by Perry's spouse, Georgianna Maule-Ffinch ("Maule-Ffinch"), as the sole trustee of the Maule-Ffinch Trust, for the benefit of Maule-Ffinch and her children. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
These shares are owned directly by Maule-Ffinch.
These shares are owned directly by Doland R. Leo, Trustee of Pensus Limited Trust dated 06/12/2010 FBO Georgianna Maule-Ffinch (the "Pensus Limited Trust") for the benefit of Maule-Ffinch. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Executive Chairman of the Board of Directors
/s/ Mark Heinen, Attorney-in-Fact for David P. Perry
2023-07-31
/s/ Mark Heinen, Attorney-in-Fact for David P. Perry 2015 Trust
2023-07-31